Tortoise Investment Management LLC Acquires 46 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Tortoise Investment Management LLC grew its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 7.5% in the fourth quarter, HoldingsChannel reports. The fund owned 657 shares of the healthcare conglomerate’s stock after buying an additional 46 shares during the period. Tortoise Investment Management LLC’s holdings in UnitedHealth Group were worth $332,000 as of its most recent filing with the SEC.

Other institutional investors also recently modified their holdings of the company. Paragon Private Wealth Management LLC lifted its position in UnitedHealth Group by 6.4% during the fourth quarter. Paragon Private Wealth Management LLC now owns 1,138 shares of the healthcare conglomerate’s stock worth $575,000 after purchasing an additional 68 shares during the period. Meriwether Wealth & Planning LLC bought a new stake in UnitedHealth Group during the fourth quarter worth about $264,000. Tower Wealth Partners Inc. lifted its position in UnitedHealth Group by 6.0% during the fourth quarter. Tower Wealth Partners Inc. now owns 1,099 shares of the healthcare conglomerate’s stock worth $556,000 after purchasing an additional 62 shares during the period. Daiwa Securities Group Inc. lifted its position in UnitedHealth Group by 2.2% during the fourth quarter. Daiwa Securities Group Inc. now owns 213,016 shares of the healthcare conglomerate’s stock worth $107,757,000 after purchasing an additional 4,523 shares during the period. Finally, SLT Holdings LLC bought a new stake in UnitedHealth Group during the fourth quarter worth about $3,459,000. Institutional investors own 87.86% of the company’s stock.

Insiders Place Their Bets

In other news, Director Timothy Patrick Flynn bought 1,000 shares of the business’s stock in a transaction that occurred on Friday, January 17th. The shares were bought at an average cost of $511.57 per share, for a total transaction of $511,570.00. Following the acquisition, the director now directly owns 4,500 shares in the company, valued at approximately $2,302,065. This trade represents a 28.57 % increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Company insiders own 0.33% of the company’s stock.

UnitedHealth Group Stock Performance

NYSE:UNH opened at $479.14 on Tuesday. The company has a market capitalization of $438.28 billion, a PE ratio of 30.91, a P/E/G ratio of 1.37 and a beta of 0.62. The company has a 50 day simple moving average of $513.21 and a two-hundred day simple moving average of $552.69. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $630.73.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, beating analysts’ consensus estimates of $6.74 by $0.07. The business had revenue of $100.81 billion during the quarter, compared to the consensus estimate of $101.60 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The company’s revenue for the quarter was up 6.8% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $5.83 EPS. Research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th will be issued a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.75%. The ex-dividend date of this dividend is Monday, March 10th. UnitedHealth Group’s payout ratio is 54.19%.

Analysts Set New Price Targets

Several research firms recently weighed in on UNH. Piper Sandler cut their price objective on shares of UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating for the company in a research report on Thursday, January 2nd. Truist Financial dropped their target price on shares of UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating for the company in a report on Monday, January 6th. Wells Fargo & Company dropped their target price on shares of UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating for the company in a report on Tuesday, January 28th. Oppenheimer increased their target price on shares of UnitedHealth Group from $610.00 to $640.00 and gave the stock an “outperform” rating in a report on Friday, December 6th. Finally, Deutsche Bank Aktiengesellschaft increased their target price on shares of UnitedHealth Group from $595.00 to $625.00 and gave the stock a “buy” rating in a report on Tuesday, December 3rd. One analyst has rated the stock with a hold rating, twenty have given a buy rating and two have given a strong buy rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Buy” and an average price target of $629.32.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.